Related Experiment Videos
5-Hydroxyindole-secreting rectal carcinoid tumour
Gut
|May 1, 1972
Summary
This study details a rare case of a 5-hydroxyindole-secreting rectal carcinoid tumor, the second documented instance. Despite the tumor, the patient showed no clinical signs of carcinoid syndrome.
Area of Science:
- Oncology
- Endocrinology
- Gastroenterology
Background:
- Carcinoid tumors are neuroendocrine neoplasms that can secrete various hormones.
- Rectal carcinoid tumors are rare, and those secreting 5-hydroxyindole are exceptionally uncommon.
- Carcinoid syndrome is a clinical manifestation of carcinoid tumors, often associated with hormone hypersecretion.
Purpose of the Study:
- To report a rare case of a rectal carcinoid tumor secreting 5-hydroxyindole.
- To investigate the clinical presentation and biochemical findings in a patient with this rare tumor type.
- To explore potential mechanisms underlying the absence of carcinoid syndrome despite hormone secretion.
Main Methods:
- Case report and clinical data review.
- Biochemical analysis of tumor markers and secreted substances.
- Histopathological examination of tumor tissue.
Main Results:
- A patient presented with a rectal carcinoid tumor confirmed to secrete 5-hydroxyindole.
- No clinical symptoms of carcinoid syndrome were observed in the patient.
- Prostaglandin-like substances were identified in hepatic metastases.
Conclusions:
- Rectal carcinoid tumors secreting 5-hydroxyindole are exceedingly rare.
- The absence of carcinoid syndrome in this case suggests complex regulatory mechanisms or alternative pathways of hormone metabolism.
- The presence of prostaglandin-like substances in metastases may indicate a role in tumor progression or associated symptoms.